Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Yoon's approval rating plunges to all-time low

    Yoon's approval rating plunges to all-time low
  2. 2

    Bae Doo-na shares portraying Korean identity in Hollywood's 'Rebel Moon'

    Bae Doo-na shares portraying Korean identity in Hollywood's 'Rebel Moon'
  3. 3

    S. Korea votes in favor of Palestinian bid for UN membership

    S. Korea votes in favor of Palestinian bid for UN membership
  4. 4

    [From the Scene] Monks, Buddhists hail return of remains of Buddhas

    [From the Scene] Monks, Buddhists hail return of remains of Buddhas
  5. 5

    Medical schools granted enrollment quota flexibility for next year

    Medical schools granted enrollment quota flexibility for next year
  1. 6

    Yoon offers first one-on-one meeting with opposition leader next week

    Yoon offers first one-on-one meeting with opposition leader next week
  2. 7

    France rejects opening Paris flight routes to T'way Air, deals blow to Korean Air merger

    France rejects opening Paris flight routes to T'way Air, deals blow to Korean Air merger
  3. 8

    Chinese man behind drug scam targeting teens nabbed in Cambodia

    Chinese man behind drug scam targeting teens nabbed in Cambodia
  4. 9

    [Graphic News] French bulldog most popular breed in US, Maltese most popular in Korea

    [Graphic News] French bulldog most popular breed in US, Maltese most popular in Korea
  5. 10

    Iran fires air defense batteries in provinces as sound of explosions heard near Isfahan

    Iran fires air defense batteries in provinces as sound of explosions heard near Isfahan
피터빈트

[EQUITIES] Shinhan Investment forecasts Daewoong Pharmaceutical to post earnings decline in Q2

By Korea Herald

Published : July 15, 2016 - 18:15

    • Link copied

[THE INVESTOR] Shinhan Investment expects Daewoong Pharmaceutical’s second quarter operating profit to fall below market estimates, with the figure reaching 9.2 billion won (US$ ) that reflects a 43.7 percent downturn on-year.

Sales are expected to decline 4.2 percent to 194 billion won, mostly due to increased expenses, including those involved with research and development, which are expected to reach 26.3 billion won. The figure reflects a 2 billion won increase, on-year, Shinhan said. 

(123rf) (123rf)

In the third quarter, the brokerage said Daewoong would post sales of 199 billion won to reflect a 7 percent fall, while sales fall 27.8 percent to 11.1 billion won on-year.

By Kim Ji-hyun (jemmie@heraldcoro.com)

More from Headlines